ArticleFrontiers in medicine2026

Case Report: Acquired CDKN2A/B deletion and mTOR inhibitor resistance in TSC2-mutant metastatic epithelioid angiomyolipoma.

Shuai He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.